LFE life therapeutics limited

Sydney - Wednesday - September 6: (RWE Aust Business News) -...

  1. 56,627 Posts.
    lightbulb Created with Sketch. 267
    Sydney - Wednesday - September 6: (RWE Aust Business News) - Life
    Therapeutics (ASX:LFE) will supply Cangene Corp with anti-anthrax plasma
    to produce a hyperimmune product for the US Department of Health and
    Human Services.
    This is a $US143m project for Cangene under Project BioShield to
    produce 10,000 doses of anthrax immune globulin for treating inhalational
    anthrax.
 
watchlist Created with Sketch. Add LFE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.